BRIEF-Sobi says wins FDA approval for higher strength of Orfadin

* Says the Food and Drug Administration (FDA) has approved a

higher strength 20 mg capsule of Orfadin (nitisinone) for the

treatment of Hereditary Tyrosinaemia type-1 (HT-1)

Read more